NASDAQ: MGLN - Magellan Health, Inc.

Yield per half year: -0.3579%
Sector: Healthcare

Magellan Health, Inc.

Underestimation
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
9/10
7.95 48.77 -83.7% 25.32 -68.61%
P/S 0.5 33.76 -98.52%
P/BV 1.3 4.82 -73.03%
P/FCF 6.4 60.98 -89.5%
Ev/Ebitda 16.66 -22.12 -175.31%
Ev/S 0.4128 22.56 -98.17%
Ev/FCF 5.12 68.75 -92.56%
E/P 0.1193 0.0178 571.22%
Efficiency
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
1/10
0.6 4.83 -87.58% 6 -90%
ROE 16.91 9.61 76.03%
ROA 8.82 0.3359 2525.74%
ROIC 13.4 7.63 75.52%
ROS 6.16 -25.17 -124.47%
ROCE 0 15.33 -100%
Debt
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
1/10
4.69 -3.67 -227.9% 2.95 59.15%
Nеt Debt/Ebitda 0 -3.44 -100%
Debt/Ratio 0.1674 0.1972 -15.07%
Debt/Equity 0 1.54 -100%
Debt/Net Income 1.89 10.31 -81.62%
Dividends
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5496 -100% 0 0%
Number of years of dividend growth 0 0.0789 -100%
DSI 0 0.2043 -100%
Average dividend growth 0 0.0591 -100%
Average percentage for 5 years 0 0.4924 -100%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector -0.5496
Growth impulse
Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue 5 years
0/10
-17.47 -56.89 -69.29%
Growth impulse Ebitda 5 years 51.44 -64.81 -179.37%
Growth impulse Net Income 5 years 169.51 -58.33 -390.61%
Growth impulse FCF 5 years 270.67 -47 -675.89%
Growth impulse EPS 5 years 151 -32.41 -565.91%
IP Score
5.3/10

Similar companies

Amgen

Alexion

ABIOMED

Gilead Sciences